Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional)
Key Information
Due Date: October 1, 2024
Agency: U.S. Department of Health and Human Services (HHS)
Source: Federal
Funding Category:
Health & Human Services
Funding Amount: Not Specified
Funding Type: Grant
Match Required: No
Contact Info:
grantsinfo@nih.gov
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Overview
To qualify, their proposal has to incorporate a new technical approach or instrument. This innovation must have been developed via support from NCI's Innovative Molecular Analysis Technologies (IMAT) program. The intention of the grant is to incentivize independent validation and fast track the use of new technologies within applicable research communities.
As part of the NCI IMAT program, the grant also seeks to promote interdisciplinary collaboration in the creation of innovative tools and methods. All of these endeavors are expected to enable more effective and efficient cancer research, ultimately accelerating scientific discovery in the field.
Key Dates
Open Date: November 28, 2023
Application Due Date: October 1, 2024
Estimated Award Date: Not Specified
Additional Details
Eligible Activities
- Research and Development
Eligible Applicants
- State governments
- County governments
- City, village or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Private institutions of higher education
- Small businesses